Israel’s Kyma Medical Technologies has developed a radio frequency-based technology device to monitor fluids in the lungs – an early sign of congestive heart failure. Kyma has just been acquired by US medical device company ZOLL for a minimum of $35 million.
http://jewishbusinessnews.com/2015/09/18/zoll-acquires-israeli-kyma-medical-for-35-million/